Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT₆ antagonists

Bioorg Med Chem. 2014 Mar 1;22(5):1782-90. doi: 10.1016/j.bmc.2014.01.003. Epub 2014 Jan 9.

Abstract

Comprehensive structure activity relationship (SAR) studies were conducted on a focused screening hit, 2-(methylthio)-3-(phenylsulfonyl)-4H-pyrido[1,2-a]pyrimidin-4-imine (1, IC50: 4.0 nM), as 5-HT6 selective antagonists. Activity was improved some 2-4 fold when small, electron-donating groups were added to the central core as observed in 19, 20 and 26. Molecular docking of key compounds in a homology model of the human 5-HT6 receptor was used to rationalize our structure-activity relationship (SAR) findings. In pharmacokinetic experiments, compound 1 displayed good brain uptake in rats following intra-peritoneal administration, but limited oral bioavailability.

Keywords: 5-HT(6) antagonist; Alzheimer’s disease; Cognition; Feeding behavior; Obesity.

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Animals
  • Humans
  • Imines / pharmacokinetics*
  • Imines / pharmacology
  • Molecular Docking Simulation
  • Rats
  • Receptors, Serotonin / therapeutic use*
  • Structure-Activity Relationship

Substances

  • Imines
  • Receptors, Serotonin
  • serotonin 6 receptor